- Home
- SND vs WHWK Comparison
SND vs WHWK Comparison
Compare SND & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SND
- WHWK
- Stock Information
- Founded
- SND 2011
- WHWK 2007
- Country
- SND United States
- WHWK United States
- Employees
- SND N/A
- WHWK N/A
- Industry
- SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- SND Industrials
- WHWK Health Care
- Exchange
- SND Nasdaq
- WHWK Nasdaq
- Market Cap
- SND 85.6M
- WHWK 95.2M
- IPO Year
- SND 2016
- WHWK N/A
- Fundamental
- Price
- SND $2.15
- WHWK $2.40
- Analyst Decision
- SND
- WHWK
- Analyst Count
- SND 0
- WHWK 0
- Target Price
- SND N/A
- WHWK N/A
- AVG Volume (30 Days)
- SND 99.1K
- WHWK 5.2M
- Earning Date
- SND 11-04-2025
- WHWK 11-05-2025
- Dividend Yield
- SND 4.65%
- WHWK N/A
- EPS Growth
- SND N/A
- WHWK N/A
- EPS
- SND 0.02
- WHWK N/A
- Revenue
- SND $305,848,000.00
- WHWK $21,596,000.00
- Revenue This Year
- SND N/A
- WHWK N/A
- Revenue Next Year
- SND N/A
- WHWK N/A
- P/E Ratio
- SND $104.70
- WHWK N/A
- Revenue Growth
- SND 3.43
- WHWK N/A
- 52 Week Low
- SND $1.76
- WHWK $1.39
- 52 Week High
- SND $2.80
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- SND 51.86
- WHWK 55.06
- Support Level
- SND $2.11
- WHWK $2.28
- Resistance Level
- SND $2.30
- WHWK $2.49
- Average True Range (ATR)
- SND 0.08
- WHWK 0.34
- MACD
- SND -0.00
- WHWK -0.01
- Stochastic Oscillator
- SND 42.31
- WHWK 27.90
About SND Smart Sand Inc.
Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.